# Remifentanil Versus Sufentanil for Intubation Condition Without Myorelaxant

> **NCT01910285** · PHASE4 · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 70 (actual)

## Conditions studied

- Anaesthetic Induction

## Interventions

- **DRUG:** Remifentanyl - sufentanil placebo
- **DRUG:** Sufentanil - remifentanyl placebo

## Key facts

- **NCT ID:** NCT01910285
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01910285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01910285, "Remifentanil Versus Sufentanil for Intubation Condition Without Myorelaxant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01910285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*